Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Celogos S.A.
DescriptionNot disclosed
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat stress urinary incontinence (SUI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today